Drug Shortage Report for TEVA-PINDOLOL
Report ID | 92212 |
Drug Identification Number | 00869007 |
Brand name | TEVA-PINDOLOL |
Common or Proper name | PINDOLOL |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PINDOLOL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C07AA |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-08-22 |
Estimated end date | 2021-05-31 |
Actual end date | 2021-06-02 |
Shortage status | Resolved |
Updated date | 2021-06-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2021-06-03 | French | Compare |
v10 | 2021-06-03 | English | Compare |
v9 | 2020-07-16 | French | Compare |
v8 | 2020-07-16 | English | Compare |
v7 | 2020-01-09 | French | Compare |
v6 | 2020-01-09 | English | Compare |
v5 | 2019-11-07 | French | Compare |
v4 | 2019-11-07 | English | Compare |
v3 | 2019-08-23 | English | Compare |
v2 | 2019-08-22 | French | Compare |
v1 | 2019-08-22 | English | Compare |
Showing 1 to 11 of 11